News story: Evaluating medical innovations: apply for funding

image_pdfimage_print

Life sciences is one of the defining industries of the UK, with over 5,000 companies and 250,000 employees, and a turnover of £70.3 billion. It is also a sector that fosters growth, with more than 95% of life sciences businesses being micro, small or medium-sized enterprises (SMEs).

However, a 2016 Accelerated Access Review revealed that life sciences SMEs often face obstacles in presenting real-world evidence – within an NHS setting – to support their efforts to get their innovations commissioned within the NHS to help patients.

Up to £1.5 million is available in a competition through Innovate UK and the Office for Life Sciences to support evaluating cutting-edge devices, diagnostics and digital technologies in a real-world clinical setting.

Performance and effectiveness

The competition will support SMEs to develop an evidence base for how their products and services perform in NHS settings. SMEs can choose between 1 of 2 options for projects:

  • support collecting clinical performance and cost effectiveness. Total project costs can be up to £250,000
  • support to develop detailed and feasible plans for the collection of data, with total eligible project costs up to £50,000

Projects must:

  • have a product that aligns with at least one NHS priority healthcare area, as detailed in the NHS Long Term Plan
  • have a product currently available for the NHS to purchase but has been marketed in the UK for less than 5 years

In the competition priority will be given to projects related to:

  • ageing well
  • cancer
  • digital transformation
  • learning disabilities and autism
  • mental health
  • personalised care
  • prevention

Competition information

  • the competition will open on 22 April 2019, and close at midday on 3 July 2019
  • to lead the project, you must be a micro, small or medium-sized enterprise based in the UK
  • up to £250,000 including VAT is available
  • projects must start by 12 December 2019, and be completed by the end of December 2020

Leave a Reply

Your email address will not be published.